2025 HCPCS Code Q5126
Injection, bevacizumab-maly, biosimilar, (alymsys), 10 mg
| Short Description | Inj alymsys 10 mg |
| HCPCS Action Code | N - No maintenance for this code |
| HCPCS Coverage Code | C - Carrier judgment |
| HCPCS Code Added Date | January 01, 2023 |
| HCPCS Action Effective Date | January 01, 2023 |
| HCPCS Pricing Indicator Code | 51 - Drugs |
| HCPCS Type Of Service Code | 1 - Medical care |
| HCPCS Multiple Pricing Indicator Code | A - Not applicable as HCPCS priced under one methodology |
| HCPCS Anesthesia Base Unit Quantity | 0 |
| HCPCS Coverage Issues Manual Reference Section Number |
Check Similar HCPCS Codes
- Q0507 - Misc sup/acc ext vad
- Q0508 - Mis sup/acc imp vad
- Q0509 - Mis sup/ac imp vad nopay med
- Q0510 - Dispens fee immunosupressive
- Q0511 - Sup fee antiem,antica,immuno
- Q0512 - Px sup fee anti-can sub pres
- Q0513 - Disp fee inhal drugs/30 days
- Q0514 - Disp fee inhal drugs/90 days
- Q0515 - Sermorelin acetate injection
- Q0516 - Supply fee hiv prep 30-days
- Q0517 - Supply fee hiv prep 60-days
- Q0518 - Supply fee hiv prep 90-days
- Q1004 - Ntiol category 4
- Q1005 - Ntiol category 5
- Q2004 - Bladder calculi irrig sol
- Q2009 - Fosphenytoin inj pe
- Q2017 - Teniposide, 50 mg
- Q2026 - Radiesse injection
- Q2028 - Inj, sculptra, 0.5mg
- Q2034 - Agriflu vaccine